Somaang Menocha
About Somaang Menocha
Somaang Menocha is a Scientist specializing in Myeloid Biology at Bristol Myers Squibb in the San Francisco Bay Area, with extensive experience in immuno-oncology research and a strong academic background.
Current Role at Bristol Myers Squibb
Somaang Menocha currently works as a Scientist in Myeloid Biology at Bristol Myers Squibb. He is based in the San Francisco Bay Area. As a scientist in this role, he focuses on advancing research in myeloid cell biology, contributing to the company's immuno-oncology projects.
Previous Positions at Bristol Myers Squibb
Before his current role, Somaang Menocha held two other positions at Bristol Myers Squibb. From 2020 to 2021, he served as a Senior Associate Scientist in Myeloid Biology for 9 months. Prior to that, he was an Associate Research Scientist II in IO Discovery from 2019 to 2020, a position he held for a year. Both roles were situated in the San Francisco Bay Area.
Research Experience at Nationwide Children's Hospital
Somaang Menocha worked as a Research Associate at Nationwide Children's Hospital from 2016 to 2019. During his 3-year tenure in Columbus, Ohio Area, he contributed to various research projects, gaining substantial experience in biological research methodologies and advanced laboratory techniques.
Education and Academic Roles
Somaang Menocha earned his Master's degree from the University at Buffalo, The State University of New York, where he studied from 2013 to 2015. Prior to that, he achieved a Bachelor's degree from Amity University, studying from 2009 to 2013. He also served as a Teaching Assistant at The Research Foundation for SUNY for 2 months in 2015 and held the position of Graduate Research Assistant at University at Buffalo from 2013 to 2015.
Research and Publications
Somaang Menocha has published research on myeloid cell biology in peer-reviewed journals. His work has been recognized and presented at prestigious forums such as the American Association of Immunologists (AAI) annual meeting. He developed a novel assay for evaluating myeloid cell function and collaborated with cross-functional teams to advance immuno-oncology projects. Additionally, he received a grant for research on myeloid cell differentiation.